基本信息
浏览量:12
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
José L. Molinuevo (MD, PhD), neurologist; his clinical work and research activities are related with neurodegenerative diseases, mostly Alzheimer’s disease (AD) and related disorders. He undertook his MD career at the University of Valencia, his neurology training at Hospital Clinic in Barcelona, and his PhD, on Parkinson’s disease, at the University of Barcelona. He directed the Alzheimer’s disease and other cognitive disorders unit at the Hospital Clinic de Barcelona since 2003, which includes a genetic counselling program for monogenic dementias (PICOGEN) until 2016. He is currently the Barcelonabeta Brain Research Center (BBRC) Scientific Director since 2014. The BBRC is mainly dedicated to research on Alzheimer’s disease (AD) prevention from a clinical, cognitive, genetic, and biomarker, including wet and neuroimaging, perspective. As the BBRC Scientific Director, Dr Molinuevo leads the Clinical Research Unit as well as coordinates the research carried out in the different Units that are part of the BBRC: Cognitive Research, Neuroimaging Research, Epidemiology Research and Clinical Operations.
He is a member of the European Alzheimer Disease Consortium, of the dementia panel for the European Association of Neurology, of the Alzheimer Biomarker Standarization Initiative (ABSI), the Spanish coordinator of the BIOMARKAPD of the Joint Programming on Neurodegenerative Diseases, partner of several Innovative Medicine Initiative consortiums and part of the AD International Working Group, Subjective Cognitive Decline Initiative (SCD-I) Working Group and the NIA-AA network for developing new research criteria. He is principal investigator of multiple clinical trials and research studies on AD and, with an h-index of 47, he has published over 240 international scientific papers that have been cited 8000+ times, several books and over 20 book chapters on neurodegenerative diseases. He has been part of the board of directors of the Spanish Neurological Society from 2000-2002, has coordinated the dementia scientific group from 2006-2008 and awarded with the 2010 AD scientific prize of the Spanish Neurological Society. In addition, he has provided scientific advice or has been an investigator or data monitoring board member for Novartis, Pfizer, Eisai, Janssen-Cilag, Lundbeck, Roche, Bayer, Bristol-Myers Squibb, GE Health Care, Merz, MSD, GlaxoSmithKline, Astra-Zeneca, Avid, Lilly, Boehringer-Inghelmein, Biokit, Piramal, IBL and Fujireibio-Europe.
研究兴趣
论文共 570 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Neurologyno. 6 (2024): e208053-e208053
Neurobiology of Agingno. S10 (2024)
Irene Cumplido-Mayoral,Anna Brugulat-Serrat,Gonzalo Sánchez-Benavides,Armand González-Escalante, Federica Anastasi,Marta Milà-Alomà, David López-Martos,Muge Akinci,Carles Falcón,Mahnaz Shekari,Raffaele Cacciaglia,Eider M Arenaza-Urquijo,
The Lancet Healthy Longevityno. 4 (2024): e276-e286
ALZHEIMERS & DEMENTIAno. 3 (2024): 1703-1715
ALZHEIMERS & DEMENTIAno. 1 (2024): 483-493
D. Angioni,O. Hansson, R. J. Bateman, C. Rabe, M. Toloue, J. B. Braunstein, S. Agus,J. R. Sims, T. Bittner, M. C. Carrillo, H. Fillit,C. L. Masters,
The journal of prevention of Alzheimer's diseaseno. 3 (2023): 418-425
Irene Cumplido-Mayoral,Anna Brugulat-Serrat,Gonzalo Sánchez-Benavides, Armand G. Escalante, Federica Anastasi,Marta Milà-Alomà, David López-Martos,Muge Akinci,Carles Falcon,Mahnaz Shekari,Raffaele Cacciaglia,Eider M. Arenaza-Urquijo,
crossref(2023)
Journal of sleep researchpp.e14108-e14108, (2023)
Ilse Bader,Ilona Bader,Isadora Lopes Alves,David Vállez García, Bruno Vellas, Bruno Dubois,Mercè Boada,Marta Marquié,Daniele Altomare, Philip Scheltens,Rik Vandenberghe,Bernard Hanseeuw,
ALZHEIMERS RESEARCH & THERAPYno. 1 (2023): 1-14
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn